The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment.

Bae, Bong Kyung; Park, Hee Chul; Yoo, Gyu Sang; Choi, Moon Seok; Oh, Joo Hyun; Yu, Jeong Il

Bae, Bong Kyung; Park, Hee Chul; Yoo, Gyu Sang; Choi, Moon Seok; Oh, Joo Hyun; Yu, Jeong Il.

Afiliación

Bae BK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Park HC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Yoo GS; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Choi MS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Oh JH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Yu JI; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Cancers (Basel) ; 14(9)2022 Apr 21.

Article en En | MEDLINE | ID: mdl-35565210

Palabras clave

hepatocellular carcinoma; intrahepatic recurrence; lymphocyte-to-monocyte ratio; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; systemic inflammatory marker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google